{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:33:28Z","timestamp":1789094008391,"version":"build-2803163510"},"reference-count":282,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","award":["APVV-23-0212"],"award-info":[{"award-number":["APVV-23-0212"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","award":["62410140"],"award-info":[{"award-number":["62410140"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","award":["09I03-03-V03-00008"],"award-info":[{"award-number":["09I03-03-V03-00008"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012825","name":"International Visegrad Fund","doi-asserted-by":"publisher","award":["APVV-23-0212"],"award-info":[{"award-number":["APVV-23-0212"]}],"id":[{"id":"10.13039\/100012825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012825","name":"International Visegrad Fund","doi-asserted-by":"publisher","award":["62410140"],"award-info":[{"award-number":["62410140"]}],"id":[{"id":"10.13039\/100012825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012825","name":"International Visegrad Fund","doi-asserted-by":"publisher","award":["09I03-03-V03-00008"],"award-info":[{"award-number":["09I03-03-V03-00008"]}],"id":[{"id":"10.13039\/100012825","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Next Generation EU","award":["APVV-23-0212"],"award-info":[{"award-number":["APVV-23-0212"]}]},{"name":"European Union\u2019s Next Generation EU","award":["62410140"],"award-info":[{"award-number":["62410140"]}]},{"name":"European Union\u2019s Next Generation EU","award":["09I03-03-V03-00008"],"award-info":[{"award-number":["09I03-03-V03-00008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Hemoglobin is an oxygen-transport protein in red blood cells that interacts with multiple ligands, e.g., oxygen, carbon dioxide, carbon monoxide, and nitric oxide. Genetic variations in hemoglobin chains, such as those underlying sickle cell disease and thalassemias, present substantial clinical challenges. Here, we review the progress in research, including the use of allosteric modulators, pharmacological chaperones, and antioxidant treatments, which has begun to improve hemoglobin stability and oxygen affinity. According to UniProt (as of 7 August 2024), 819 variants of the \u03b1-hemoglobin subunit and 771 variants of the \u03b2-hemoglobin subunit have been documented, with over 116 classified as unstable. These data demonstrate the urgent need to develop variant-specific stabilizing options. Beyond small-molecule drugs\/binders, novel protein-based strategies\u2014such as engineered hemoglobin-binding proteins (including falcilysin, llama-derived nanobodies, and \u03b1-hemoglobin-stabilizing proteins)\u2014offer promising new options. As our understanding of hemoglobin\u2019s structural and functional diversity grows, so does the potential for genotype-driven approaches. Continued research into hemoglobin stabilization and ligand-binding modification may yield more precise, effective treatments and pave the way toward effective strategies for hemoglobinopathies.<\/jats:p>","DOI":"10.3390\/molecules30020385","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T11:24:56Z","timestamp":1737113096000},"page":"385","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hemoglobin Variants as Targets for Stabilizing Drugs"],"prefix":"10.3390","volume":"30","author":[{"given":"Miroslava","family":"\u017dold\u00e1kov\u00e1","sequence":"first","affiliation":[{"name":"Faculty of Science, Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice, Park Angelinum 19, 040 01 Ko\u0161ice, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Novotn\u00fd","sequence":"additional","affiliation":[{"name":"AURORA R&D s.r.o., Mojm\u00edrova 12, 040 01 Ko\u0161ice, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna P.","family":"Khakurel","sequence":"additional","affiliation":[{"name":"Extreme Light Infrastructure ERIC, Za Radnici 835, 25241 Dolni Brezany, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5271-8837","authenticated-orcid":false,"given":"Gabriel","family":"\u017dold\u00e1k","sequence":"additional","affiliation":[{"name":"Faculty of Science, Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice, Park Angelinum 19, 040 01 Ko\u0161ice, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"ref_1","first-page":"135","article-title":"Stereochemical mechanism of oxygen transport by haemoglobin","volume":"208","author":"Perutz","year":"1980","journal-title":"Proc. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/138920310790274653","article-title":"Hemoglobin and Cooperativity: Experiments and Theories","volume":"11","author":"Bellelli","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.ph.50.030188.001145","article-title":"The Bohr Effect","volume":"50","author":"Riggs","year":"1988","journal-title":"Annu. Rev. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0003-9861(69)90192-1","article-title":"Different response to organic phosphates of human fetal and adult hemoglobins","volume":"129","author":"Tyuma","year":"1969","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbapap.2011.02.013","article-title":"Hemoglobin\u2013ligand binding: Understanding Hb function and allostery on atomic level","volume":"1814","author":"Safo","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) Proteins Proteom."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-3-030-41769-7_14","article-title":"Hemoglobin: Structure, Function and Allostery","volume":"94","author":"Ahmed","year":"2020","journal-title":"Subcell. Biochem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1021\/jm00106a041","article-title":"Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents","volume":"34","author":"Randad","year":"1991","journal-title":"J. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.bbapap.2008.04.021","article-title":"Ligand reactivity and allosteric regulation of hemoglobin-based oxygen carriers","volume":"1784","author":"Ronda","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA) Proteins Proteom."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/iub.6","article-title":"Cooperativity and allostery in haemoglobin function","volume":"60","author":"Ciaccio","year":"2008","journal-title":"IUBMB Life"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1021\/bi800816v","article-title":"Interfacial and Distal-Heme Pocket Mutations Exhibit Additive Effects on the Structure and Function of Hemoglobin","volume":"47","author":"Maillett","year":"2008","journal-title":"Biochemistry"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Brunori, M., and Miele, A.E. (2023). Modulation of Allosteric Control and Evolution of Hemoglobin. Biomolecules, 13.","DOI":"10.3390\/biom13030572"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Storz, J.F. (2018). Hemoglobin structure and allosteric mechanism. Hemoglobin, Oxford University Press.","DOI":"10.1093\/oso\/9780198810681.001.0001"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1113\/jphysiol.1934.sp003213","article-title":"The chemical relationships and physiological importance of carbamino compounds of CO2 with h\u00e6moglobin","volume":"83","author":"Ferguson","year":"1934","journal-title":"J. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1021\/bi030172j","article-title":"Crystallographic Analysis of the Interaction of Nitric Oxide with Quaternary-T Human Hemoglobin","volume":"43","author":"Chan","year":"2003","journal-title":"Biochemistry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.molmed.2009.08.002","article-title":"Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation","volume":"15","author":"Allen","year":"2009","journal-title":"Trends Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1016\/S0021-9258(19)42050-4","article-title":"The Binding of Phosphorylated Red Cell Metabolites to Human Hemoglobin A","volume":"249","author":"Hamasaki","year":"1974","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/00365517109080229","article-title":"Affinity of Human Hemoglobin a to 2,3\u2014Diphosphoglycerate. Effect of Hemoglobin Concentration and of pH","volume":"27","author":"Garby","year":"1971","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1432-1033.1979.tb04194.x","article-title":"The pH Dependence of the Binding of d-Glycerate 2,3-Bisphosphate to Deoxyhemoglobin and Oxyhemoglobin. Determination of the Number of Binding Sites in Oxyhemoglobin","volume":"100","author":"Beek","year":"1979","journal-title":"Eur. J. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Isaacks, R.E. (1988). Can Metabolites Contribute in Regulating Blood Oxygen Affinity?. Advances in Experimental Medicine and Biology, Springer.","DOI":"10.1007\/978-1-4684-5481-9_11"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj3420581","article-title":"Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: Equations and parameter refinement","volume":"342","author":"Mulquiney","year":"1999","journal-title":"Biochem. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41594-017-0019-z","article-title":"Visualization and analysis of non-covalent contacts using the Protein Contacts Atlas","volume":"25","author":"Kayikci","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood-2023-188988","article-title":"Structural Effect of G\u03b3 and A\u03b3 Globin Chains in Fetal Hemoglobin Tetramer","volume":"142","author":"Centurion","year":"2023","journal-title":"Blood"},{"key":"ref_23","unstructured":"Chestnut, D.H. (1999). Hematologic and coagulation disorders. Obstetric Anesthesia: Principles and Practice, Mosby Inc.. [2nd ed.]."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/iub.4","article-title":"Disorders of the synthesis of human fetal hemoglobin","volume":"60","author":"Manca","year":"2008","journal-title":"IUBMB Life"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1373\/clinchem.2018.295766","article-title":"Diagnosis of Hemoglobinopathy and \u03b2-Thalassemia by 21 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometry and Tandem Mass Spectrometry of Hemoglobin from Blood","volume":"65","author":"He","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.21037\/atm.2019.07.97","article-title":"Diagnosis of hemoglobinopathy and \u03b2-thalassemia by 21-Tesla Fourier transform ion cyclotron resonance mass spectrometry","volume":"7","author":"Kim","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5581\/1516-8484.20110059","article-title":"What influences Hb fetal production in adulthood?","volume":"33","author":"Carrocini","year":"2011","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hempe, J.M., and Craver, R.D. (1999). Laboratory Diagnosis of Structural Hemoglobinopathies and Thalassemias by Capillary Isoelectric Focusing. Clinical Applications of Capillary Electrophoresis, Humana Press.","DOI":"10.1385\/1-59259-689-4:81"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/193229680900300307","article-title":"A Review of Variant Hemoglobins Interfering with Hemoglobin A1c Measurement","volume":"3","author":"Little","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Fontana, L., Alahouzou, Z., Miccio, A., and Antoniou, P. (2023). Epigenetic Regulation of \u03b2-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing. Genes, 14.","DOI":"10.3390\/genes14030577"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/3601","article-title":"Alpha-hemoglobin stabilizing protein: Molecular function and clinical correlation","volume":"15","author":"Turbpaiboon","year":"2010","journal-title":"Front. Biosci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Cardiero, G., Musollino, G., Prezioso, R., and Lacerra, G. (2021). mRNA Analysis of Frameshift Mutations with Stop Codon in the Last Exon: The Case of Hemoglobins Campania [\u03b11 cod95 (\u2212C)] and Sciacca [\u03b11 cod109 (\u2212C)]. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101390"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"eabb7107","DOI":"10.1126\/sciadv.abb7107","article-title":"Supramolecular nanosubstrate\u2013mediated delivery system enables CRISPR-Cas9 knockin of hemoglobin beta gene for hemoglobinopathies","volume":"6","author":"Yang","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.ymthe.2021.04.037","article-title":"Coordinated \u03b2-globin expression and \u03b12-globin reduction in a multiplex lentiviral gene therapy vector for \u03b2-thalassemia","volume":"29","author":"Nualkaew","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"14055","DOI":"10.1038\/mtm.2014.55","article-title":"Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathies","volume":"1","author":"Kiem","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"a011858","DOI":"10.1101\/cshperspect.a011858","article-title":"Hemoglobin Variants: Biochemical Properties and Clinical Correlates","volume":"3","author":"Thom","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40246-022-00407-x","article-title":"Expanding ACMG variant classification guidelines into a general framework","volume":"16","author":"Masson","year":"2022","journal-title":"Hum. Genom."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Balding, D., Moltke, I., and Marioni, J. (2019). Variant Interpretation and Genomic Medicine. Handbook of Statistical Genomics, John Wiley & Sons Ltd.","DOI":"10.1002\/9781119487845"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chen, J.-M., Masson, E., Zou, W.-B., Liao, Z., G\u00e9nin, E., Cooper, D.N., and F\u00e9rec, C. (2023). Validation of the ACMG\/AMP guidelines-based seven-category variant classification system. medRxiv.","DOI":"10.1101\/2023.01.23.23284909"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jmg-2023-109488","article-title":"Variant reclassification and clinical implications","volume":"61","author":"Walsh","year":"2024","journal-title":"J. Med. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ajcp\/aqx047","article-title":"Molecular Diagnosis of Thalassemias and Hemoglobinopathies","volume":"148","author":"Sabath","year":"2017","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/humu.24280","article-title":"Adapting the ACMG\/AMP variant classification framework: A perspective from the ClinGen Hemoglobinopathy Variant Curation Expert Panel","volume":"43","author":"Kountouris","year":"2021","journal-title":"Hum. Mutat."},{"key":"ref_44","first-page":"426","article-title":"The impact of variant classification on the clinical management of hereditary cancer syndromes","volume":"21","author":"Turner","year":"2019","journal-title":"Anesth. Analg."},{"key":"ref_45","first-page":"5","article-title":"The Blood Blues: A Review on Methemoglobinemia","volume":"9","author":"David","year":"2018","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4037\/ccn2002.22.4.50","article-title":"Methemoglobinemia: A case study","volume":"22","author":"Boylston","year":"2002","journal-title":"Crit. Care Nurse"},{"key":"ref_47","first-page":"203","article-title":"Methemoglobinemia: A systematic review of the pathophysiology, detection, and treatment","volume":"83","author":"Ashurst","year":"2011","journal-title":"Delw. Med. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1590\/S0034-70942008000600011","article-title":"Metemoglobinemia: Do diagn\u00f3stico ao tratamento","volume":"58","author":"Nascimento","year":"2008","journal-title":"Braz. J. Anesthesiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/ajh.26340","article-title":"Recommendations for diagnosis and treatment of methemoglobinemia","volume":"96","author":"Iolascon","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.md.0000141096.00377.3f","article-title":"Acquired Methemoglobinemia: A retrospective series of 138 cases at 2 teaching hospitals","volume":"83","author":"Wise","year":"2004","journal-title":"Medicine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/cem.2020.33","article-title":"Acquired methemoglobinemia presenting to the pediatric emergency department: A clinical challenge","volume":"22","author":"Friedman","year":"2020","journal-title":"CJEM"},{"key":"ref_52","unstructured":"Karna, B., Jha, S.K., and Al Zaabi, E. (2024, August 12). Hemoglobin C Disease, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559043\/."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI105670","article-title":"Pathogenesis of Hemolytic Anemia in Homozygous Hemoglobin C Disease","volume":"46","author":"Charache","year":"1967","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.29074\/ascls.2019001412","article-title":"Development of a Microscopic Method to Identify Hemoglobin C Conditions for Use in Developing Countries","volume":"32","author":"Schmidt","year":"2019","journal-title":"Am. Soc. Clin. Lab. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1096\/fasebj.30.1_supplement.1082.4","article-title":"Development of an easy, inexpensive, and precise method to identify Hemoglobin C for use in underdeveloped countries","volume":"30","author":"Ohiri","year":"2016","journal-title":"FASEB J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Verra, F., Simpore, J., Warimwe, G.M., Tetteh, K.K., Howard, T., Osier, F.H.A., Bancone, G., Avellino, P., Blot, I., and Fegan, G. (2007). Haemoglobin C and S Role in Acquired Immunity against Plasmodium falciparum Malaria. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000978"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1515\/cmble-2015-0043","article-title":"Coexistence of rare variant HbD Punjab [\u03b12\u03b22121(Glu\u2192Gln)] and alpha 3.7 kb deletion in a young boy of Hindu family in West Bengal, India","volume":"20","author":"Ghosh","year":"2015","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2014.01.028","article-title":"Clinical and hematological presentation among Indian patients with common hemoglobin variants","volume":"431","author":"Italia","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/MPH.0000000000000049","article-title":"HbSD-Punjab","volume":"36","author":"Oberoi","year":"2014","journal-title":"J. Pediatr. Hematol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1590\/S1516-31802012000400008","article-title":"Molecular characterization of hemoglobin D Punjab traits and clinical-hematological profile of the patients","volume":"130","author":"Pandey","year":"2012","journal-title":"Sao Paulo Med. J."},{"key":"ref_61","first-page":"105","article-title":"Coinheritance of HbD-Punjab\/\u03b2+-thalassemia (IVSI+5 G-C) in patient with Gilbert\u2019s syndrome","volume":"90","author":"Pivnik","year":"2018","journal-title":"Ter. Arkh."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V47.1.113.113","article-title":"Globin chain synthesis in HbD (Punjab)-beta-thalassemia","volume":"47","author":"Rieder","year":"1976","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/421330","article-title":"Extended Linkage Disequilibrium Surrounding the Hemoglobin E Variant Due to Malarial Selection","volume":"74","author":"Ohashi","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1081\/HEM-120040334","article-title":"The \u2018Hot Spot\u2019 of Hb E [\u03b226(B8)Glu\u2192Lys] in Southeast Asia: \u03b2-Globin Anomalies in the Lao Theung Population of Southern Laos","volume":"28","author":"Flatz","year":"2004","journal-title":"Hemoglobin"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"23452","DOI":"10.1074\/jbc.M110.183186","article-title":"Structural and Functional Studies Indicating Altered Redox Properties of Hemoglobin E","volume":"286","author":"Roche","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.redox.2016.03.004","article-title":"Oxidative instability of hemoglobin E (\u03b226 Glu\u2192Lys) is increased in the presence of free \u03b1 subunits and reversed by \u03b1-hemoglobin stabilizing protein (AHSP): Relevance to HbE\/\u03b2-thalassemia","volume":"8","author":"Strader","year":"2016","journal-title":"Redox Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygeno.2006.03.009","article-title":"A humanized BAC transgenic\/knockout mouse model for HbE\/\u03b2-thalassemia","volume":"88","author":"Jamsai","year":"2006","journal-title":"Genomics"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s10528-008-9185-3","article-title":"Lack of Association of the HbE Variant with Protection from Cerebral Malaria in Thailand","volume":"46","author":"Naka","year":"2008","journal-title":"Biochem. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1110\/ps.11701","article-title":"Oligomerization and ligand binding in a homotetrameric hemoglobin: Two high-resolution crystal structures of hemoglobin Bart\u2019s (\u03b34), a marker for \u03b1-thalassemia","volume":"10","author":"Kidd","year":"2001","journal-title":"Protein Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1469-1809.1967.tb00031.x","article-title":"Haemoglobin Bart\u2019s hydrops foetalis in Thailand","volume":"30","author":"Pootrakul","year":"1967","journal-title":"Ann. Hum. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.1975.tb01816.x","article-title":"Haemoglobin Bart\u2019s in Saudi Arabia","volume":"29","author":"Pembrey","year":"1975","journal-title":"Br. J. Haematol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"13128","DOI":"10.1016\/S0021-9258(18)43016-5","article-title":"Crystallization and preliminary X-ray diffraction studies of methemoglobin Bart\u2019s","volume":"256","author":"Czerwinski","year":"1981","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/03630269909005700","article-title":"Rapid and Accurate Quantitation of Hb Bart\u2019s and Hb H Using Weak Cation Exchange High Performance Liquid Chromatography: Correlation with the \u03b1-Thalassemia Genotype","volume":"23","author":"Papassotiriou","year":"1999","journal-title":"Hemoglobin"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/03630260500454550","article-title":"Hb Bart\u2019s in Cord Blood: An Accurate Indicator of \u03b1-Thalassemia","volume":"30","author":"Rugless","year":"2006","journal-title":"Hemoglobin"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0022-2836(72)90287-2","article-title":"Circular dichroism and absorption spectra of haemoglobin Bart\u2019s","volume":"65","author":"Sasazuki","year":"1972","journal-title":"J. Mol. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.1972.tb08788.x","article-title":"Haemoglobin Bart\u2019s in Newborn Nigerians","volume":"22","author":"Esan","year":"1972","journal-title":"Br. J. Haematol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1016\/S0021-9258(19)42099-1","article-title":"Allosteric Transition and Ligand Binding in Hemoglobin Chesapeake","volume":"249","author":"Gibson","year":"1974","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1203\/00006450-197907000-00011","article-title":"The effect of hemoglobin F-Chesapeake (\u03b1292 Arg.\u2192Leu\u03b32) on fetal oxygen affinity and erythropoiesis","volume":"13","author":"Jones","year":"1979","journal-title":"Pediatr. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1749-6632.1974.tb21901.x","article-title":"A manifestation of abnormal hemoglobins of man: Altered oxygen affinity. Hemoglobin Chesapeake: From the clinic to the laboratory, and back again","volume":"241","author":"Charache","year":"1974","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1081\/HEM-58571","article-title":"Hemoglobins with High Oxygen Affinity Leading to Erythrocytosis. New Variants and New Concepts","volume":"29","author":"Wajcman","year":"2005","journal-title":"Hemoglobin"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/03630260802173429","article-title":"Hb Lepore-Leiden: A New \u03b4\/\u03b2 Rearrangement Associated with a \u03b2-Thalassemia Minor Phenotype","volume":"32","author":"Harteveld","year":"2008","journal-title":"Hemoglobin"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Pirastru, M., Manca, L., Trova, S., and Mereu, P. (2017). Biochemical and Molecular Analysis of the Hb Lepore Boston Washington in a Syrian Homozygous Child. BioMed Res. Int., 2017.","DOI":"10.1155\/2017\/1261972"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0609.1995.tb01822.x","article-title":"Association of Hb S\/Hb lepore and \u03b4\u03b2-thalassemia\/Hb lepore in Sicilian patients: Review of the presence of Hb lepore in Sicily","volume":"55","author":"Mirabile","year":"1995","journal-title":"Eur. J. Haematol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ajh.2830440310","article-title":"Hemoglobin sickle-lepore: Report of two siblings and review of the literature","volume":"44","author":"Seward","year":"1993","journal-title":"Am. J. Hematol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03630267809007068","article-title":"Hemoglobins Lepore and Anti-Lepore","volume":"2","author":"Efremov","year":"1978","journal-title":"Hemoglobin"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bcmd.2009.11.008","article-title":"Interactions of hemoglobin Lepore (deltabeta hybrid hemoglobin) with v arious hemoglobinopathies: A molecular and hematological characteristi cs and differential diagnosis","volume":"44","author":"Chaibunruang","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/03630269.2021.1956945","article-title":"Hb Lepore-Hong Kong: First Report of a Novel \u03b4\/\u03b2-Globin Gene Fusion in a Chinese Family","volume":"45","author":"Jiang","year":"2021","journal-title":"Hemoglobin"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2141.1982.tb02796.x","article-title":"Haemoglobin Constant Spring has an unstable \u03b1 chain messenger RNA","volume":"51","author":"Hunt","year":"1982","journal-title":"Br. J. Haematol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ajh.2830380405","article-title":"Hemoglobin constant spring in bangkok: Molecular screening by selective enzymatic amplification of the \u03b12-globin gene","volume":"38","author":"Thonglairoam","year":"1991","journal-title":"Am. J. Hematol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bcmd.2013.12.002","article-title":"Hemoglobin Constant Spring is markedly high in women of an ethnic minority group in Vietnam: A community-based survey and hematologic features","volume":"52","author":"Nguyen","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Jomoui, W., Fucharoen, G., Sanchaisuriya, K., Nguyen, V.H., and Fucharoen, S. (2015). Hemoglobin Constant Spring among Southeast Asian Populations: Haplotypic Heterogeneities and Phylogenetic Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145230"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/01.mph.0000243662.56432.37","article-title":"Anemia and Hydrops in a Fetus with Homozygous Hemoglobin Constant Spring","volume":"28","author":"Charoenkwan","year":"2006","journal-title":"J. Pediatr. Hematol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V73.7.1987.1987","article-title":"Selective enzymatic amplification of alpha 2-globin DNA for detection of the hemoglobin Constant Spring mutation","volume":"73","author":"Kropp","year":"1989","journal-title":"Blood"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1373\/clinchem.2007.078824","article-title":"Hemoglobin Constant Spring Can Interfere with Glycated Hemoglobin Measurements by Boronate Affinity Chromatography","volume":"53","author":"Roberts","year":"2007","journal-title":"Clin. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/(SICI)1096-8652(199904)60:4<279::AID-AJH5>3.0.CO;2-2","article-title":"Hemoglobin S\/O(Arab): Thirteen new cases and review of the lit-erature","volume":"60","author":"Zimmerman","year":"1999","journal-title":"Am. J. Hematol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/pbc.24414","article-title":"Clinical and hematological features of homozygous hemoglobin O-Arab [beta 121 Glu \u2192 Lys]","volume":"60","author":"Dror","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_97","first-page":"163","article-title":"Hemoglobin O Arab in Ivory Coast and western Africa","volume":"52","author":"Sanogo","year":"1992","journal-title":"Med. Trop. (Mars)"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000207414","article-title":"Human Haemoglobins and Haemoglobinopathies in Arabia: Hb O Arab in Saudi Arabia","volume":"63","author":"Lehmann","year":"1980","journal-title":"Acta Haematol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM197012242832601","article-title":"Hemoglobin O Arab in Four Negro Families and Its Interaction with Hemoglobin S and Hemoglobin C","volume":"283","author":"Milner","year":"1970","journal-title":"N. Engl. J. Med."},{"key":"ref_100","first-page":"637","article-title":"Hemoglobin O Arab: About 20 cases","volume":"85","author":"Hafsia","year":"2007","journal-title":"Tunis. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/03630269709000666","article-title":"HB Seal Rock [(\u03b12)142 Term\u2192glu, Codon 142 TAA\u2192GAA]: An Extended \u03b1 Chain Variant Associated with Anemia, Microcytosis, and \u03b1-Thalassemia-2 (-3.7 KB)","volume":"21","author":"Merritt","year":"1997","journal-title":"Hemoglobin"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3324\/haematol.2009.012971","article-title":"Chronic hemolytic anemia due to novel -globin chain variants: Critical location of the mutation within the gene sequence for a dominant effect","volume":"94","author":"Moradkhani","year":"2009","journal-title":"Haematologica"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ajh.20860","article-title":"Hb Indianapolis [\u03b2112 (G14) Cys\u2192Arg] as the probable cause of moderate hemolytic anemia and renal damage in a Brazilian patient","volume":"82","author":"Fattori","year":"2007","journal-title":"Am. J. Hematol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/03630269.2015.1113990","article-title":"Ten Years of Routine\u03b1- and\u03b2-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations","volume":"40","author":"Henderson","year":"2016","journal-title":"Hemoglobin"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000208220","article-title":"Haemoglobin Madrid \u03b2115 (G17) Alanine\u2192Proline: An Unstable Variant Associated with Haemolytic Anaemia","volume":"52","author":"Outeirino","year":"1974","journal-title":"Acta Haematol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/03630260009003432","article-title":"Hb Madrid [\u03b2115(G17)Ala\u2192Pro] in a Korean Family with Chronic Hemolytic Anemia","volume":"24","author":"Kim","year":"2000","journal-title":"Hemoglobin"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1081\/HEM-47613","article-title":"Hb Showa-Yakushiji [beta110(G12)Leu-->Pro] in four unrelated patients from west Bengal","volume":"29","author":"Edison","year":"2005","journal-title":"Hemoglobin"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1081\/HEM-120016378","article-title":"Hb Santander [\u03b234(B16)Val\u2192Asp (GTC \u2192 GAC)]: A New Unstable Variant Found as a De Novo Mutation in a Spanish Patient","volume":"27","author":"Villegas","year":"2003","journal-title":"Hemoglobin"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/03630268108991834","article-title":"A New Unstable Hemoglobin, Hb Yokohama \u03b231(B13)LEU \u2192 Pro, Causing Hemolytic Anemia","volume":"5","author":"Nakatsuji","year":"1981","journal-title":"Hemoglobin"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1182\/blood.V36.2.209.209","article-title":"Hemoglobin-Seattle (\u03b12A\u03b2276 Glu): An Unstable Hemoglobin Causing Chronic Hemolytic Anemia","volume":"36","author":"Huehns","year":"1970","journal-title":"Blood"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/03630260500307626","article-title":"Two Unstable \u03b2 Chain Variants Associated with \u03b2-Thalassemia: Hb Miami [\u03b2116(G18)His\u2192Pro], and Hb Hershey [\u03b270(E14)Ala\u2192Gly], and a Second Unstable Hb Variant at \u03b270: Hb Abington [\u03b270(E14)Ala\u2192Pro]","volume":"29","author":"Hoyer","year":"2005","journal-title":"Hemoglobin"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Li, W. (2019). Biophysical Basis of Hb-S Polymerization in Red Blood Cell Sickling. bioRxiv.","DOI":"10.1101\/676957"},{"key":"ref_113","unstructured":"Karen, C. (2018). Sickle Cell Disease: A Genetic Disorder of Beta-Globin. Thalassemia and Other Hemolytic Anemias, IntechOpen."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jtha.2022.10.024","article-title":"Targeting the von Willebrand Factor\u2013ADAMTS-13 axis in sickle cell disease","volume":"21","author":"Ellsworth","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Nader, E., Romana, M., and Connes, P. (2020). The Red Blood Cell\u2014Inflammation Vicious Circle in Sickle Cell Disease. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00454"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.aje.a010288","article-title":"Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review","volume":"151","author":"Yang","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"ref_117","first-page":"146","article-title":"A Review on Sickle Cells Disease","volume":"3","year":"2019","journal-title":"Sci. J. Med. Res."},{"key":"ref_118","first-page":"S226","article-title":"CRISPR\/Cas9\u03b2-globin Gene Targeting in Human Haematopoietic Stem Cells","volume":"140","author":"Poli","year":"2017","journal-title":"Nature"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.omtm.2020.04.013","article-title":"\u03b2T87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells","volume":"17","author":"Demirci","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"101028","DOI":"10.1016\/j.mam.2021.101028","article-title":"Thalassemias: From gene to therapy","volume":"84","author":"Quattrocchi","year":"2022","journal-title":"Mol. Asp. Med."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Angastiniotis, M., and Lobitz, S. (2019). Thalassemias: An Overview. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5010016"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/bmj.314.7095.1675","article-title":"Fortnightly review: The thalassaemias","volume":"314","author":"Weatherall","year":"1997","journal-title":"BMJ"},{"key":"ref_123","first-page":"339","article-title":"Alpha and beta thalassemia","volume":"80","author":"Muncie","year":"2009","journal-title":"Am. Fam. Physician"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcmd.2017.02.002","article-title":"Globins, from Genes to Physiology and Diseases","volume":"70","author":"Vernimmen","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5222\/TP.2021.10820","article-title":"Thalassemia","volume":"2","author":"Aksu","year":"2021","journal-title":"Trends Pediatr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.46966\/msjar.v3i1.36","article-title":"Overview on thalassemia: A review article","volume":"3","author":"Meri","year":"2022","journal-title":"Med. Sci. J. Adv. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1172\/JCI110706","article-title":"Association of hemoglobin C with erythrocyte ghosts","volume":"70","author":"Reiss","year":"1982","journal-title":"J. Clin. Investig."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.4103\/jmms.jmms_165_22","article-title":"Review of Clinical and Hematological Profile of Hemoglobin D Cases in a Single Centre","volume":"25","author":"Singh","year":"2023","journal-title":"J. Mar. Med. Soc."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"A570","DOI":"10.21276\/apalm.2906","article-title":"HbE Variants: An Experience from Tertiary Care Centre of Eastern India","volume":"7","author":"Mukherjee","year":"2020","journal-title":"Ann. Pathol. Lab. Med."},{"key":"ref_130","first-page":"41","article-title":"Oxidative denaturation in congenital hemolytic anemias: The unstable hemoglobins","volume":"27","author":"Winterbourn","year":"1990","journal-title":"Semin. Hematol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0005-2795(75)90190-7","article-title":"Hemoglobin wood \u03b297(FG4) His \u2192 Leu: A new high-oxygen-affinity hemoglobin associated with familial erythrocytosis","volume":"400","author":"Taketa","year":"1975","journal-title":"Biochim. Biophys. Acta (BBA) Protein Struct."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1182\/blood.V31.5.623.623","article-title":"Erythrocytosis Secondary to Increased Oxygen Affinity of a Mutant Hemoglobin, Hemoglobin Kempsey","volume":"31","author":"Reed","year":"1968","journal-title":"Blood"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13256-022-03374-y","article-title":"Unstable hemoglobin Montreal II uncovered in an adult with unexplained hemolysis exacerbated by a presumed viral infection: A case report","volume":"16","author":"Medri","year":"2022","journal-title":"J. Med. Case Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/etc.3983","article-title":"Hematological indices of injury to lightly oiled birds from the Deepwater Horizon oil spill","volume":"37","author":"Fallon","year":"2018","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ecoenv.2017.07.030","article-title":"Weathered MC252 crude oil-induced anemia and abnormal erythroid morphology in double-crested cormorants (Phalacrocorax auritus) with light microscopic and ultrastructural description of Heinz bodies","volume":"146","author":"Harr","year":"2017","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/ajh.20128","article-title":"Severe hemolytic anemia associated with Hb Volga [\u03b227(B9)Ala\u2192Asp]: GCC\u2192GAC at codon 27 in a Turkish family","volume":"76","author":"Karaaslan","year":"2004","journal-title":"Am. J. Hematol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1600-0609.2011.01606.x","article-title":"Severity ranking of non-deletional alpha thalassemic alleles: Insights from an Omani family study","volume":"86","author":"Wali","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/asheducation-2015.1.392","article-title":"Diagnosis and management of rare congenital nonimmune hemolytic disease","volume":"2015","author":"Gallagher","year":"2015","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/etc.2058","article-title":"A practical quantification method for Heinz bodies in birds applicable to rapid response field scenarios","volume":"32","author":"Fallon","year":"2013","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e31078","DOI":"10.1002\/pbc.31078","article-title":"Infantile pyknocytosis, a neonatal hemolytic anemia with Heinz bodies: A cohort study","volume":"71","author":"Drouilly","year":"2024","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Furdak, P., Bartosz, G., Stefaniuk, I., Cieniek, B., Bieszczad-Bedrejczuk, E., Soszy\u0144ski, M., and Sadowska-Bartosz, I. (2024). Effect of Garlic Extract on the Erythrocyte as a Simple Model Cell. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105115"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1590\/S1678-91992011000100002","article-title":"Allium species poisoning in dogs and cats","volume":"17","author":"Salgado","year":"2011","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"ref_143","first-page":"232","article-title":"Effects of abnormal Hb on red cell membranes","volume":"47","author":"Ideguchi","year":"1999","journal-title":"Rinsho Byori"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.3390\/s100807099","article-title":"Molecular Biosensing Mechanisms in the Spleen for the Removal of Aged and Damaged Red Cells from the Blood Circulation","volume":"10","author":"Sugawara","year":"2010","journal-title":"Sensors"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/00365510601047910","article-title":"Inherited, non-spherocytic haemolysis due to deficiency of glucose-6-phosphate dehydrogenase","volume":"67","author":"Ronquist","year":"2007","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1172\/JCI106421","article-title":"The role of hemoglobin heme loss in Heinz body formation: Studies with a partially heme-deficient hemoglobin and with genetically unstable hemoglobins","volume":"49","author":"Jacob","year":"1970","journal-title":"J. Clin. Investig."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1073\/pnas.65.3.697","article-title":"Unstable Hemoglobins: The Role of Heme Loss in Heinz Body Formation","volume":"65","author":"Jacob","year":"1970","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1172\/JCI107806","article-title":"Studies of Hemoglobin Denaturation and Heinz Body Formation in the Unstable Hemoglobins","volume":"54","author":"Winterbourn","year":"1974","journal-title":"J. Clin. Investig."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jmg.24.12.761","article-title":"Mapping the human alpha globin gene complex to 16p13.2\u2014Pter","volume":"24","author":"Simmers","year":"1987","journal-title":"J. Med. Genet."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/jmg.24.1.39","article-title":"High resolution gene mapping of the human alpha globin locus","volume":"24","author":"Nicholls","year":"1987","journal-title":"J. Med. Genet."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/hmg\/10.4.339","article-title":"Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16","volume":"10","author":"Daniels","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1073\/pnas.83.14.5165","article-title":"Analysis of the human alpha-globin gene cluster reveals a highly informative genetic locus","volume":"83","author":"Higgs","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bcmd.2010.05.010","article-title":"Novel large deletions in the human \u03b1-globin gene cluster: Clarifying the HS-40 long-range regulatory role in the native chromosome environment","volume":"45","author":"Coelho","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.1985.tb17174.x","article-title":"Molecular Rearrangements of the Human \u03b1-Globin Gene Cluster","volume":"445","author":"Higgs","year":"1985","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/blood.V76.1.221.221","article-title":"Alpha-thalassemia caused by a large (62 kb) deletion upstream of the human alpha globin gene cluster","volume":"76","author":"Hatton","year":"1990","journal-title":"Blood"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000492147","article-title":"A New Trans-Acting Modulator of Fetal Hemoglobin?","volume":"140","author":"Steinberg","year":"2018","journal-title":"Acta Haematol."},{"key":"ref_157","first-page":"61","article-title":"Beta-thalassemia","volume":"12","author":"Cao","year":"2010","journal-title":"Anesth. Analg."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/gbe\/evt029","article-title":"Evolutionary Constraints in the \u03b2-Globin Cluster: The Signature of Purifying Selection at the \u03b4-Globin (HBD) Locus and Its Role in Developmental Gene Regulation","volume":"5","author":"Moleirinho","year":"2013","journal-title":"Genome Biol. Evol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000132156","article-title":"High-resolution chromosomal localization of the \u03b2-gene of the human \u03b2-globin gene complex by in situ hybridization","volume":"39","author":"Lin","year":"1985","journal-title":"Cytogenet. Genome Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1073\/pnas.76.10.5239","article-title":"Precise localization of human beta-globin gene complex on chromosome 11","volume":"76","author":"Gusella","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1073\/pnas.75.3.1456","article-title":"Chromosomal localization of human \u03b2 globin gene on human chromosome 11 in somatic cell hybrids","volume":"75","author":"Deisseroth","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOP.0b013e3283420fd0","article-title":"Update on fetal hemoglobin gene regulation in hemoglobinopathies","volume":"23","author":"Orkin","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"19359","DOI":"10.1074\/jbc.273.31.19359","article-title":"Normal and Abnormal Protein Subunit Interactions in Hemoglobins","volume":"273","author":"Manning","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1021\/bi011329f","article-title":"The Role of \u03b2 Chains in the Control of the Hemoglobin Oxygen Binding Function: Chimeric Human\/Mouse Proteins, Structure, and Function","volume":"40","author":"Kidd","year":"2001","journal-title":"Biochemistry"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"14179","DOI":"10.1074\/jbc.273.23.14179","article-title":"Role of \u03b2112 Cys (G14) in Homo-(\u03b24) and Hetero-(\u03b12\u03b22) Tetramer Hemoglobin Formation","volume":"273","author":"Yamaguchi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1006\/jmbi.1994.1191","article-title":"The 1\u00b78 \u00c5 Structure of Carbonmonoxy-\u03b24 Hemoglobin: Analysis of a Homotetramer with the R Quaternary Structure of Liganded \u03b12\u03b22 Hemoglobin","volume":"236","author":"Borgstahl","year":"1994","journal-title":"J. Mol. Biol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1016\/S0021-9258(18)90956-7","article-title":"The interaction of hemoglobin with the cytoplasmic domain of band 3 of the human erythrocyte membrane","volume":"259","author":"Chatterjee","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"40602","DOI":"10.1074\/jbc.M206084200","article-title":"Biophysical Characterization of the \u03b1-Globin Binding Protein \u03b1-Hemoglobin Stabilizing Protein","volume":"277","author":"Gell","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Domingues-Hamdi, E., Vasseur, C., Fournier, J.-B., Marden, M.C., Wajcman, H., and Baudin-Creuza, V. (2014). Role of \u03b1-Globin H Helix in the Building of Tetrameric Human Hemoglobin: Interaction with \u03b1-Hemoglobin Stabilizing Protein (AHSP) and Heme Molecule. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111395"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2004.11.025","article-title":"Molecular Mechanism of AHSP-Mediated Stabilization of \u03b1-Hemoglobin","volume":"119","author":"Feng","year":"2004","journal-title":"Cell"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI31664","article-title":"An erythroid chaperone that facilitates folding of \u03b1-globin subunits for hemoglobin synthesis","volume":"117","author":"Yu","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/ars.2009.2780","article-title":"The Role of Alpha-Hemoglobin Stabilizing Protein in Redox Chemistry, Denaturation, and Hemoglobin Assembly","volume":"12","author":"Mollan","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1182\/blood-2008-12-196030","article-title":"Analysis of human \u03b1 globin gene mutations that impair binding to the \u03b1 hemoglobin stabilizing protein","volume":"113","author":"Yu","year":"2009","journal-title":"Blood"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3324\/haematol.13490","article-title":"Controlling-globin: A review of-globin expression and its impact on -thalassemia","volume":"93","author":"Voon","year":"2008","journal-title":"Haematologica"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1179\/135100007X200209","article-title":"Glucose-6-phosphate dehydrogenase\u2014From oxidative stress to cellular functions and degenerative diseases","volume":"12","author":"Ho","year":"2007","journal-title":"Redox Rep."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000343123","article-title":"Life and Death of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Erythrocytes\u2014Role of Redox Stress and Band 3 Modifications","volume":"39","author":"Arese","year":"2012","journal-title":"Transfus. Med. Hemotherapy"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V67.2.331.331","article-title":"Excess release of ferriheme in G6PD-deficient erythrocytes: Possible cause of hemolysis and resistance to malaria","volume":"67","author":"Janney","year":"1986","journal-title":"Blood"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V77.9.2059.2059","article-title":"NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes","volume":"77","author":"Scott","year":"1991","journal-title":"Blood"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1096\/fasebj.14.1.111","article-title":"An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis","volume":"14","author":"Nicol","year":"2000","journal-title":"FASEB J."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/vox.12068","article-title":"Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: The unknown risks","volume":"105","author":"Francis","year":"2013","journal-title":"Vox Sang."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/156652408786241384","article-title":"The Role of Oxidative Stress in Hemolytic Anemia","volume":"8","author":"Fibach","year":"2008","journal-title":"Curr. Mol. Med."},{"key":"ref_182","first-page":"22","article-title":"The Effect of N-Acetyl Cysteine and Vitamin E on Oxidative Status and Hemoglobin Level in Transfusion-Dependent Thalassemia Patients: A Systematic Review and Meta-Analysis","volume":"15","author":"Haghpanah","year":"2021","journal-title":"Iran. J. Blood Cancer"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Halima, W.M.A.B., Hannemann, A., Rees, D., Brewin, J., and Gibson, J. (2019). The Effect of Antioxidants on the Properties of Red Blood Cells from P atients with Sickle Cell Anemia. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.00976"},{"key":"ref_184","first-page":"376","article-title":"Storing red blood cells with vitamin C and N-acetylcysteine prevents oxidative stress-related lesions: A metabolomics overview","volume":"12","author":"Pallotta","year":"2014","journal-title":"Blood Transfus."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cca.2020.07.020","article-title":"Antioxidant nutrients and hemolysis in sickle cell disease","volume":"510","author":"Delesderrier","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.2010.05577.x","article-title":"The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia","volume":"1202","author":"Fibach","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cphy.c120006","article-title":"Porphyrin and heme metabolism and the porphyrias","volume":"3","author":"Bonkovsky","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjmed.2014.10.026","article-title":"Role of Delta-aminolevulinic Acid in the Symptoms of Acute Porphyria","volume":"128","author":"Bissell","year":"2014","journal-title":"Am. J. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM197509182931210","article-title":"Hematin and Porphyria","volume":"293","author":"Watson","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2007-1007140","article-title":"Acute Porphyria: Treatment with Heme","volume":"18","author":"Tenhunen","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"26424","DOI":"10.1074\/jbc.M110.215772","article-title":"Lon Peptidase 1 (LONP1)-dependent Breakdown of Mitochondrial 5-Aminolevulinic Acid Synthase Protein by Heme in Human Liver Cells","volume":"286","author":"Tian","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pharmthera.2011.06.001","article-title":"Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity","volume":"132","author":"Hift","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"22010","DOI":"10.1016\/S0021-9258(18)54738-4","article-title":"Biosynthesis of delta-aminolevulinic acid and the regulation of heme formation by immature erythroid cells in man","volume":"266","author":"Gardner","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1100\/tsw.2002.295","article-title":"Hydroxyurea Treatment for Sickle Cell Disease","volume":"2","author":"Steinberg","year":"2002","journal-title":"Sci. World J."},{"key":"ref_195","first-page":"95","article-title":"Therapies to increase fetal hemoglobin in sickle cell disease","volume":"2","author":"Steinberg","year":"2003","journal-title":"Curr. Hematol. Rep."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/asheducation-2006.1.58","article-title":"Induction of Fetal Hemoglobin in the Treatment of Sickle Cell Disease","volume":"2006","author":"Fathallah","year":"2006","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI200316672","article-title":"Hydroxyurea induces fetal hemoglobin by the nitric oxide\u2013dependent activation of soluble guanylyl cyclase","volume":"111","author":"Cokic","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJM199004123221504","article-title":"Hematologic Responses of Patients with Sickle Cell Disease to Treatment with Hydroxyurea","volume":"322","author":"Rodgers","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_199","first-page":"541","article-title":"Hydroxyurea therapy: Improving the lives of patients with sickle cell disease","volume":"32","author":"Anderson","year":"2006","journal-title":"Pediatr. Nurs."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJM199008093230602","article-title":"Treatment of Sickle Cell Anemia with Hydroxyurea and Erythropoietin","volume":"323","author":"Goldberg","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_201","first-page":"5","article-title":"Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease","volume":"19","author":"Dover","year":"1992","journal-title":"Semin. Oncol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1182\/blood-2022-169125","article-title":"Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat","volume":"140","author":"Grace","year":"2022","journal-title":"Blood"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1902678","article-title":"Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency","volume":"381","author":"Grace","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.htct.2021.10.048","article-title":"Results from a phase 2 study of mitapivat in adults with non\u2013transfusion-dependent alpha- or beta-thalassemia","volume":"43","author":"Kuo","year":"2021","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1182\/blood-2022-163493","article-title":"Mitapivat Improves Markers of Erythropoietic Activity in Long-Term Study of Adults with Alpha- or Beta-Non-Transfusion-Dependent Thalassemia","volume":"140","author":"Kuo","year":"2022","journal-title":"Blood"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.HS9.0000821432.34545.49","article-title":"S116: Long-term efficacy and safety of the oral pyruvate kinase activator mitapivat in adults with non\u2014Transfusion-dependent alpha- or beta-thalassemia","volume":"6","author":"Kuo","year":"2022","journal-title":"HemaSphere"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood-2021-145398","article-title":"Mitapivat (AG-348) Demonstrates Safety, Tolerability, and Improvements in Anemia, Hemolysis, Oxygen Affinity, and Hemoglobin S Polymerization Kinetics in Adults with Sickle Cell Disease: A Phase 1 Dose Escalation Study","volume":"138","author":"Xu","year":"2021","journal-title":"Blood"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1358\/dot.2023.59.3.3521880","article-title":"Mitapivat for sickle cell disease and thalassemia","volume":"59","author":"Pilo","year":"2023","journal-title":"Drugs Today"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"100790","DOI":"10.1016\/j.xcrm.2022.100790","article-title":"Right in time: Mitapivat for the treatment of anemia in \u03b1- and \u03b2-thalassemia","volume":"3","author":"Musallam","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Olubiyi, O.O., Olagunju, M.O., and Strodel, B. (2019). Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease. Molecules, 24.","DOI":"10.3390\/molecules24244551"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"103555","DOI":"10.1016\/j.transci.2022.103555","article-title":"Sickle cell disease in the new era: Advances in drug treatment","volume":"61","author":"Lee","year":"2022","journal-title":"Transfus. Apher. Sci."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.exphem.2020.08.008","article-title":"Efficacy and safety of recently approved drugs for sickle cell disease: A review of clinical trials","volume":"92","author":"Ali","year":"2020","journal-title":"Exp. Hematol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/21678707.2018.1471983","article-title":"Advances in new drug therapies for the management of sickle cell disease","volume":"6","author":"Ataga","year":"2018","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/14656566.2018.1548610","article-title":"Emerging pharmacotherapeutic approaches for the management of sickle cell disease","volume":"20","author":"Torres","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3324\/haematol.2018.207357","article-title":"Emerging disease-modifying therapies for sickle cell disease","volume":"104","author":"Carden","year":"2019","journal-title":"Haematologica"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Huang, B., Ghatge, M.S., Donkor, A.K., Musayev, F.N., Deshpande, T.M., Al-Awadh, M., Alhashimi, R.T., Zhu, H., Omar, A.M., and Telen, M.J. (2022). Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease. Molecules, 27.","DOI":"10.3390\/molecules27206835"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1021\/cb500230b","article-title":"Identification of a Small Molecule that Increases Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte Sickling","volume":"9","author":"Nakagawa","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1039\/C7MT00104E","article-title":"Targeting \u03b2Cys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects","volume":"9","author":"Kassa","year":"2017","journal-title":"Metallomics"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Kassa, T., Wood, F., Strader, M.B., and Alayash, A.I. (2019). Antisickling Drugs Targeting \u03b2Cys93 Reduce Iron Oxidation and Oxidative Changes in Sickle Cell Hemoglobin. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.00931"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"14704","DOI":"10.1016\/S0021-9258(18)66928-5","article-title":"Covalent binding of glutathione to hemoglobin. I. Inhibition of hemoglobin S polymerization","volume":"261","author":"Garel","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_221","first-page":"559","article-title":"Inhibition of erythrocyte sickling by thiol reagents","volume":"26","author":"Garel","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.05332.x","article-title":"5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells\u2020,\u2021","volume":"128","author":"Abdulmalik","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1021\/acs.molpharmaceut.7b00553","article-title":"Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease","volume":"14","author":"Xu","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V120.21.3210.3210","article-title":"A Phase 1, First-in-Man, Dose-Response Study of Aes-103 (5-HMF), an Anti-Sickling, Allosteric Modifier of Hemoglobin Oxygen Affinity in Healthy Norman Volunteers","volume":"120","author":"Stern","year":"2012","journal-title":"Blood"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Lucas, A., Ao-Ieong, E.S.Y., Williams, A.T., Jani, V.P., Muller, C.R., Yalcin, O., and Cabrales, P. (2019). Increased Hemoglobin Oxygen Affinity With 5-Hydroxymethylfurfural Supports Cardiac Function During Severe Hypoxia. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.01350"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1113\/jphysiol.2014.277681","article-title":"Effects of 5-hydroxymethyl-2-furfural on the volume and membrane permeability of red blood cells from patients with sickle cell disease","volume":"592","author":"Hannemann","year":"2014","journal-title":"J. Physiol."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Alhashimi, R.T., Ghatge, M.S., Donkor, A.K., Deshpande, T.M., Anabaraonye, N., Alramadhani, D., Danso-Danquah, R., Huang, B., Zhang, Y., and Musayev, F.N. (2022). Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease. Biomolecules, 12.","DOI":"10.3390\/biom12050696"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/jm0498001","article-title":"Structural Basis for the Potent Antisickling Effect of a Novel Class of Five-Membered Heterocyclic Aldehydic Compounds","volume":"47","author":"Safo","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.hoc.2013.11.001","article-title":"Therapeutic Strategies to Alter the Oxygen Affinity of Sickle Hemoglobin","volume":"28","author":"Safo","year":"2014","journal-title":"Hematol. Clin. N. Am."},{"key":"ref_230","first-page":"979","article-title":"Critical Redox and Allosteric Aspects of Nitric Oxide Interactions with Hemoglobin","volume":"6","author":"Bonaventura","year":"2004","journal-title":"Antioxid. Redox Signal."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"9943","DOI":"10.1073\/pnas.180155397","article-title":"Relative role of heme nitrosylation and \u03b2-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation","volume":"97","author":"Gladwin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/physiol.00042.2006","article-title":"Transport and Peripheral Bioactivities of Nitrogen Oxides Carried by Red Blood Cell Hemoglobin: Role in Oxygen Delivery","volume":"22","author":"Sonveaux","year":"2007","journal-title":"Physiology"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1126\/science.276.5321.2034","article-title":"Blood Flow Regulation by S-Nitrosohemoglobin in the Physiological Oxygen Gradient","volume":"276","author":"Stamler","year":"1997","journal-title":"Science"},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Frehm, E., Bonaventura, J., and Gow, A. (2004). Serial Review: Biomedical Implications for Hemoglobin Interactions with Nitric Oxide Serial Review Editors: Mark T. Gladwin and Rakesh Patel S-nitrosohemoglobin: An allosteric mediator of no group function in m ammalian vasculature. Free Radic. Biol. Med., 37.","DOI":"10.1016\/j.freeradbiomed.2004.04.032"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"100034","DOI":"10.1016\/j.medntd.2020.100034","article-title":"The role of hemoglobin in nitric oxide transport in vascular system","volume":"5","author":"Su","year":"2020","journal-title":"Med. Nov. Technol. Devices"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1778-428X.2007.00084.x","article-title":"The hemoglobin-nitric oxide axis: Implications for transfusion therapeutics","volume":"9","author":"Lancaster","year":"2007","journal-title":"Transfus. Altern. Transfus. Med."},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Omar, A.M., Abdulmalik, O., Ghatge, M.S., Muhammad, Y.A., Paredes, S.D., El-Araby, M.E., and Safo, M.K. (2020). An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling. Biomolecules, 10.","DOI":"10.3390\/biom10111508"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.bmc.2018.04.015","article-title":"Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease","volume":"26","author":"Pagare","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/13543776.2022.1994945","article-title":"Modulating hemoglobin allostery for treatment of sickle cell disease: Current progress and intellectual property","volume":"32","author":"Pagare","year":"2021","journal-title":"Expert Opin. Ther. Patents"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/acs.jmedchem.0c01518","article-title":"PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease","volume":"64","author":"Gopalsamy","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3324\/haematol.2018.207530","article-title":"Targeting sickle cell disease root-cause pathophysiology with small molecules","volume":"104","author":"Saunthararajah","year":"2019","journal-title":"Haematologica"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood-2019-128270","article-title":"A Novel Non-Covalent Modulator of Hemoglobin Improves Anemia and Reduces Sickling in a Mouse Model of Sickle Cell Disease","volume":"134","author":"Knee","year":"2019","journal-title":"Blood"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.14264","article-title":"New developments in anti-sickling agents: Can drugs directly prevent the polymerization of sickle haemoglobin in vivo?","volume":"175","author":"Oder","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/acsmedchemlett.6b00491","article-title":"Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin","volume":"8","author":"Metcalf","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.mayocp.2018.08.001","article-title":"Advances in the Treatment of Sickle Cell Disease","volume":"93","author":"Kapoor","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ajh.24116","article-title":"2015 Clinical trials update in sickle cell anemia","volume":"90","author":"Archer","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1107\/S2059798318009919","article-title":"Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation","volume":"74","author":"Deshpande","year":"2018","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1039\/C9MD00048H","article-title":"Synthesis of novel vanillin derivatives: Novel multi-targeted scaffold ligands against Alzheimer\u2019s disease","volume":"10","author":"Scipioni","year":"2019","journal-title":"MedChemComm"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ptr.2975","article-title":"Pharmacokinetics of vanillin and its effects on mechanical hypersensitivity in a rat model of neuropathic pain","volume":"24","author":"Beaudry","year":"2009","journal-title":"Phytother. Res."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1016\/j.bmc.2015.06.068","article-title":"Synthesis, kinetic mechanism and docking studies of vanillin derivatives as inhibitors of mushroom tyrosinase","volume":"23","author":"Ashraf","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1182\/blood.V77.6.1334.1334","article-title":"Vanillin, a potential agent for the treatment of sickle cell anemia","volume":"77","author":"Abraham","year":"1991","journal-title":"Blood"},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Abdulmalik, O., Pagare, P.P., Huang, B., Xu, G.G., Ghatge, M.S., Xu, X., Chen, Q., Anabaraonye, N., Musayev, F.N., and Omar, A.M. (2020). VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-77171-2"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"14724","DOI":"10.1021\/acs.jmedchem.0c01287","article-title":"Exploration of Structure-Activity Relationship of Aromatic Aldehydes Bearing Pyridinylmethoxy-Methyl Esters as Novel Antisickling Agents","volume":"63","author":"Pagare","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"13054","DOI":"10.1002\/anie.201405664","article-title":"Crowning Proteins: Modulating the Protein Surface Properties using Crown Ethers","volume":"53","author":"Lee","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-4838(84)90012-8","article-title":"Acylation of human hemoglobin with polyoxyethylene derivatives","volume":"791","author":"Leonard","year":"1984","journal-title":"Biochim. Biophys. Acta (BBA) Protein Struct. Mol. Enzymol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1021\/bi00153a005","article-title":"Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats","volume":"31","author":"Abraham","year":"1992","journal-title":"Biochemistry"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Sun, K., D\u2019alessandro, A., Ahmed, M.H., Zhang, Y., Song, A., Ko, T.-P., Nemkov, T., Reisz, J.A., Wu, H., and Adebiyi, M. (2017). Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-13667-8"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"25078","DOI":"10.1016\/S0021-9258(17)31501-6","article-title":"Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity","volume":"269","author":"Kaca","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"37793","DOI":"10.1074\/jbc.M111.245472","article-title":"Delineation of Lipopolysaccharide (LPS)-binding Sites on Hemoglobin: From in silico predictions to biophysical characterization","volume":"286","author":"Bahl","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Lechuga, G.C., Souza-Silva, F., Sacramento, C.Q., Trugilho, M.R.O., Valente, R.H., Napole\u00e3o-P\u00eago, P., Dias, S.S.G., Fintelman-Rodrigues, N., Temerozo, J.R., and Carels, N. (2021). SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites. Int. J. Mol. Sci., 22.","DOI":"10.1101\/2021.04.16.440124"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0005-2736(75)90357-0","article-title":"The binding of hemoglobin to membranes of normal and sickle erythrocytes","volume":"375","author":"Fischer","year":"1975","journal-title":"Biochim. Biophys. Acta (BBA) Biomembr."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1021\/bi00644a031","article-title":"Interaction of hemoglobin with red blood cell membranes as shown by a fluorescent chromophore","volume":"16","author":"Shaklai","year":"1977","journal-title":"Biochemistry"},{"key":"ref_263","first-page":"873","article-title":"Voxelotor: A Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease","volume":"11","author":"Yenamandra","year":"2020","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"513","DOI":"10.18203\/2319-2003.ijbcp20200732","article-title":"Voxelotor: Novel drug for sickle cell disease","volume":"9","author":"Singh","year":"2020","journal-title":"Int. J. Basic Clin. Pharmacol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/phar.2405","article-title":"Systematic Review of Voxelotor: A First-in-Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease","volume":"40","author":"Han","year":"2020","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2018-08-868893","article-title":"A phase 1\/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease","volume":"133","author":"Howard","year":"2019","journal-title":"Blood"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/bcp.13896","article-title":"Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease","volume":"85","author":"Hutchaleelaha","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/17474086.2021.1893688","article-title":"Voxelotor for the treatment of sickle cell disease","volume":"14","author":"Vissa","year":"2021","journal-title":"Expert Rev. Hematol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tracli.2015.01.002","article-title":"Role of alpha-hemoglobin molecular chaperone in the hemoglobin formation and clinical expression of some hemoglobinopathies","volume":"22","author":"Vasseur","year":"2015","journal-title":"Transfus. Clin. Biol."},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Favero, M.E., and Costa, F.F. (2011). Alpha-Hemoglobin-Stabilizing Protein: An Erythroid Molecular Chaperone. Biochem. Res. Int., 2011.","DOI":"10.1155\/2011\/373859"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1196\/annals.1345.013","article-title":"Role of Alpha Hemoglobin-Stabilizing Protein in Normal Erythropoiesis and \u03b2-Thalassemia","volume":"1054","author":"Weiss","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1074\/jbc.M111.313205","article-title":"Insights into Hemoglobin Assembly through in Vivo Mutagenesis of \u03b1-Hemoglobin Stabilizing Protein","volume":"287","author":"Khandros","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"32411","DOI":"10.1074\/jbc.274.45.32411","article-title":"Identification and Characterization of Falcilysin, a Metallopeptidase Involved in Hemoglobin Catabolism within the Malaria Parasite Plasmodium falciparum","volume":"274","author":"Eggleson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.1074\/jbc.M306842200","article-title":"Plasmodium falciparum falcilysin: A metalloprotease with dual specificity","volume":"278","author":"Christina","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2958.2006.05528.x","article-title":"Subcellular multitasking\u2014Multiple destinations and roles for the Plasmodium falcilysin protease","volume":"63","author":"Ralph","year":"2007","journal-title":"Mol. Microbiol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2958.2006.05443.x","article-title":"A role for falcilysin in transit peptide degradation in the Plasmodium falciparum apicoplast","volume":"63","author":"Ponpuak","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.bmcl.2018.04.010","article-title":"Development of piperazine-based hydroxamic acid inhibitors against fal cilysin, an essential malarial protease","volume":"28","author":"Chance","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1021\/acscentsci.2c00998","article-title":"A cell-permeant nano-body-based degrader that induces fetal hemoglobin","volume":"8","author":"Shen","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"ref_279","first-page":"e2218959120","article-title":"Evolution of nanobodies specific for BCL11A","volume":"120","author":"Maolu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"e2935","DOI":"10.1002\/jmr.2935","article-title":"Recognition of human hemoglobin with macromolecularly imprinted polyme ric nanoparticles using non-covalent interactions","volume":"34","author":"Denizli","year":"2021","journal-title":"J. Mol. Recognit."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1107\/S1600576724005028","article-title":"On the feasibility of time-resolved X-ray powder diffraction of macromolecules using laser-driven ultrafast X-ray sources","volume":"57 Pt 4","author":"Khakurel","year":"2024","journal-title":"J. Appl. Crystallogr."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1107\/S1600576724002140","article-title":"Design and fabrication of 3D-printed in situ crystallization plates for probing microcrystals in an external electric field","volume":"57","author":"Khakurel","year":"2024","journal-title":"J. Appl. Crystallogr."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/2\/385\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:31:08Z","timestamp":1759919468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/2\/385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":282,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["molecules30020385"],"URL":"https:\/\/doi.org\/10.3390\/molecules30020385","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}